Clinical trial NCT00767039 - References

Respiratory Distress Syndrome — Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants

Citation(s)

•   Fujii A, Allen R, Doros G, O'Brien S
  Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome. J Perinatol. 2010 Oct;30(10):671-6. doi: 10.1038/jp.2010.21. Epub 2010 Mar 25
•   Fujii A
  Editorial. Are all animal derived surfactants the same? The e-NeoResearch 2011; 1 (1); 50-51.
•   Fujii AM, Bailey J, Doros G, Sampat K, Sikes NC, Mason M, Kaiser JR
  Cerebral Blood Flow Responses to Beractant and Poractant Administration. Journal of Neonatal-Perinatal Medicine 2009; 2:27-34
•   Fujii AM, Carillo M
  Animal-derived surfactant treatment of respiratory distress syndrome in premature neonates: a review. Drugs Today (Barc). 2009 Sep;45(9):697-709. doi: 1396674/dot.2009.45.9.1418185. Review.
•   Fujii AM, Editorial
  Is There Really A Clinical Difference In Surfactant Preparations? J Perinatol 2010; 30:698; doi:10,1038/jp.2010.90
•   Fujii AM, Patel SM, Allen R, Doros G, Guo CY, Testa S
  Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome. J Perinatol. 2010 Oct;30(10):665-70. doi: 10.1038/jp.2010.20. Epub 2010 Mar 25. Erratum in: J Perin

Phase 4 Study of Curosurf (Poractant) and Survanta (Beractant) Surfactant Treatment in Very Premature Infants With Respiratory Distress Syndrome.

Details for clinical trial NCT00767039